Notice To Announce Request for Information To Assist in the Development of a New Strategic Plan for the National Institute on Deafness and Other Communication Disorders, for 2022-2026, 5220-5221 [2020-01480]

Download as PDF lotter on DSKBCFDHB2PROD with NOTICES 5220 Federal Register / Vol. 85, No. 19 / Wednesday, January 29, 2020 / Notices Name of Committee: Risk, Prevention and Health Behavior Integrated Review Group; Addiction Risks and Mechanisms Study Section. Date: February 24–25, 2020. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Hotel Solamar, 435 6th Avenue, San Diego, CA 92101. Contact Person: Kristen Prentice, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3112, MSC 7808, Bethesda, MD 20892, (301) 496– 0726, prenticekj@mail.nih.gov. Name of Committee: Oncology 2— Translational Clinical Integrated Review Group; Mechanisms of Cancer Therapeutics—2 Study Section. Date: February 24–25, 2020. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road NW, Washington, DC 20015. Contact Person: Careen K. Tang-Toth, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6214, MSC 7804, Bethesda, MD 20892, (301) 435– 3504, tothct@csr.nih.gov. Name of Committee: Oncology 2— Translational Clinical Integrated Review Group; Drug Discovery and Molecular Pharmacology Study Section. Date: February 24–25, 2020. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Jeffrey Smiley, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6194, MSC 7804, Bethesda, MD 20892, 301–594– 7945, smileyja@csr.nih.gov. Name of Committee: Genes, Genomes, and Genetics Integrated Review Group; Genetics of Health and Disease Study Section. Date: February 24–25, 2020. Time: 8:00 a.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. Contact Person: Christopher Payne, Ph.D., Scientific Review Officer, Center for Scientific Review, 6701 Rockledge Drive, Bethesda, MD 20892, 301–402–3702, christopher.payne@nih.gov. Name of Committee: Oncology 2— Translational Clinical Integrated Review Group; Clinical Oncology Study Section. Date: February 24, 2020. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Ritz-Carlton Hotel, 1700 Tysons Boulevard, McLean, VA 22102. Contact Person: Malaya Chatterjee, Ph.D., Scientific Review Officer, Center for VerDate Sep<11>2014 17:27 Jan 28, 2020 Jkt 250001 Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6192, MSC 7804, Bethesda, MD 20892, 301–806– 2515, chatterm@csr.nih.gov. Name of Committee: Cell Biology Integrated Review Group; Biology of the Visual System Study Section. Date: February 24–25, 2020. Time: 8:00 a.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Michael H. Chaitin, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5202, MSC 7850, Bethesda, MD 20892, (301) 435– 0910, chaitinm@csr.nih.gov. Name of Committee: Biobehavioral and Behavioral Processes Integrated Review Group; Child Psychopathology and Developmental Disabilities Study Section. Date: February 24–25, 2020. Time: 8:00 a.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: Fairmont in Washington DC, 2401 M Street NW, Washington, DC 20037. Contact Person: Katherine Colona Morasch, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3170, Bethesda, MD 20892, (301) 594–9147, moraschkc@csr.nih.gov. Name of Committee: Healthcare Delivery and Methodologies Integrated Review Group; Community-Level Health Promotion Study Section. Date: February 24–25, 2020. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Wyndham San Antonio River Walk, 111 East Pecan Street, San Antonio, TX 78205. Contact Person: Ping Wu, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3166, Bethesda, MD 20892, 301– 451–8428, wup4@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: January 23, 2020. Tyeshia M. Roberson, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–01491 Filed 1–28–20; 8:45 am] BILLING CODE 4140–01–P PO 00000 Frm 00031 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Notice To Announce Request for Information To Assist in the Development of a New Strategic Plan for the National Institute on Deafness and Other Communication Disorders, for 2022–2026 AGENCY: National Institutes of Health, HHS. ACTION: Notice. The National Institute on Deafness and Other Communication Disorders (NIDCD) is in the process of developing a new Strategic Plan for 2022–2026 to help guide the research it supports over the next five years. Through this Request for Information, NIDCD invites researchers in academia and industry, health care professionals, patient advocates and health advocacy organizations, scientific or professional organizations, Federal agencies, and other interested members of the public to provide ideas to inform development of NIDCD’s next strategic plan. DATES: The NIDCD’s Request for Information is open for public idea submission for a period of 60 days. Ideas must be received by March 31, 2020, to ensure consideration. After the idea submission period has closed, NIDCD will consider the ideas we received in a timely manner for the development of the 2022–2026 Strategic Plan of the National Institute on Deafness and Other Communication Disorders. SUMMARY: Please visit our website to view our questions and submit your ideas to NIDCD electronically: https:// www.nidcd.nih.gov/about/strategicplan/2022-2026/2022-2026-nidcdstrategic-planning-process. NIDCD will also accept submissions via email (NIDCDStrategicPlan@nidcd.nih.gov). FOR FURTHER INFORMATION CONTACT: Laura K. Cole, Ph.D., Planning and Evaluation Officer, Science Policy and Planning Branch, National Institute on Deafness and Other Communication Disorders, NIH, 31 Center Drive, Suite 3C25, Bethesda, MD 20892. Phone: 301– 402–2313. Email: colel@nidcd.nih.gov. SUPPLEMENTARY INFORMATION: This notice is in accordance with the 21st Century Cures Act, NIH institutes are required to regularly update their strategic plans. The NIDCD’s mission is to improve the lives of the millions of people with hearing loss and other communication disorders, spanning functions of hearing, balance, taste, ADDRESSES: E:\FR\FM\29JAN1.SGM 29JAN1 Federal Register / Vol. 85, No. 19 / Wednesday, January 29, 2020 / Notices smell, voice, speech, and language. Our vision is that all those with disorders in these areas benefit from scientific discovery that informs effective and accessible treatments and improves quality of life. To get us there, NIDCD is seeking your best ideas to help as we develop our 2022–2026 Strategic Plan. Dated: January 22, 2020. Timothy J. Wheeles, Executive Officer, National Institute on Deafness and Other Communication Disorders, National Institutes of Health. [FR Doc. 2020–01480 Filed 1–28–20; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings lotter on DSKBCFDHB2PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Vascular and Hematology Integrated Review Group; Hemostasis and Thrombosis Study Section. Date: February 21, 2020. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Canopy by Hilton, 940 Rose Avenue, North Bethesda, MD 20852. Contact Person: Ai-Ping Zou, MD, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4118, MSC 7814, Bethesda, MD 20892, 301–408– 9497, zouai@csr.nih.gov. Name of Committee: Brain Disorders and Clinical Neuroscience Integrated Review Group; Aging Systems and Geriatrics Study Section. Date: February 24–25, 2020. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: The Westgate Hotel, 1055 Second Avenue, San Diego, CA 92101. Contact Person: Inese Z. Beitins, MD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6152, VerDate Sep<11>2014 17:27 Jan 28, 2020 Jkt 250001 MSC 7892, Bethesda, MD 20892, 301–435– 1034, beitinsi@csr.nih.gov. Name of Committee: Digestive, Kidney and Urological Systems Integrated Review Group; Hepatobiliary Pathophysiology Study Section. Date: February 25–26, 2020. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road NW, Washington, DC 20015. Contact Person: Jianxin Hu, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2156, Bethesda, MD 20892, 301–827–4417, jianxinh@csr.nih.gov. Name of Committee: Endocrinology, Metabolism, Nutrition and Reproductive Sciences Integrated Review Group; Cellular Aspects of Diabetes and Obesity Study Section. Date: February 25–26, 2020. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Antonello Pileggi, MD, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6166, Bethesda, MD 20892–7892, (301) 402–6297 pileggia@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Cellular Aspects of Diabetes and Obesity. Date: February 25, 2020. Time: 1:00 p.m. to 2:30 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Elaine Sierra-Rivera, Ph.D., Scientific Review Officer, EMNR IRG, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6182 MSC 7892, Bethesda, MD 20892, 301 435– 2514, riverase@csr.nih.gov. Name of Committee: Healthcare Delivery and Methodologies Integrated Review Group; Health Disparities and Equity Promotion Study Section. Date: February 26–27, 2020. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Wyndham San Antonio Riverwalk, 111 East Pecan Street, San Antonio, TX 78205. Contact Person: Jessica Bellinger, Ph.D., Scientific Review Administrator, Center for Scientific of Review, National Institutes of Health, 6701 Rockledge Drive, Room 3158, Bethesda, MD 20892, 301–827–4446, bellingerjd@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) PO 00000 Frm 00032 Fmt 4703 Sfmt 4703 5221 Dated: January 23, 2020. Ronald J. Livingston, Jr., Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–01492 Filed 1–28–20; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; Stimulating Access to Research in Residency Transition Scholar (StARRTS). Date: March 6, 2020. Time: 1:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6700– B Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: William J. Johnson, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7178, Bethesda, MD 20892–7924, 301–827– 7938, johnsonwj@nhlbi.nih.gov. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; NHLBI Catalyze Review for Small Molecules and Biologics. Date: March 9, 2020. Time: 8:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817. Contact Person: Melissa E. Nagelin, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7202, Bethesda, MD 20892, 301–435–0297, nagelinmh2@nhlbi.nih.gov. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; Clinical Ancillary Studies (R01). Date: March 10, 2020. Time: 8:30 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. E:\FR\FM\29JAN1.SGM 29JAN1

Agencies

[Federal Register Volume 85, Number 19 (Wednesday, January 29, 2020)]
[Notices]
[Pages 5220-5221]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-01480]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Notice To Announce Request for Information To Assist in the 
Development of a New Strategic Plan for the National Institute on 
Deafness and Other Communication Disorders, for 2022-2026

AGENCY: National Institutes of Health, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The National Institute on Deafness and Other Communication 
Disorders (NIDCD) is in the process of developing a new Strategic Plan 
for 2022-2026 to help guide the research it supports over the next five 
years. Through this Request for Information, NIDCD invites researchers 
in academia and industry, health care professionals, patient advocates 
and health advocacy organizations, scientific or professional 
organizations, Federal agencies, and other interested members of the 
public to provide ideas to inform development of NIDCD's next strategic 
plan.

DATES: The NIDCD's Request for Information is open for public idea 
submission for a period of 60 days. Ideas must be received by March 31, 
2020, to ensure consideration. After the idea submission period has 
closed, NIDCD will consider the ideas we received in a timely manner 
for the development of the 2022-2026 Strategic Plan of the National 
Institute on Deafness and Other Communication Disorders.

ADDRESSES: Please visit our website to view our questions and submit 
your ideas to NIDCD electronically: https://www.nidcd.nih.gov/about/strategic-plan/2022-2026/2022-2026-nidcd-strategic-planning-process. 
NIDCD will also accept submissions via email 
([email protected]).

FOR FURTHER INFORMATION CONTACT: Laura K. Cole, Ph.D., Planning and 
Evaluation Officer, Science Policy and Planning Branch, National 
Institute on Deafness and Other Communication Disorders, NIH, 31 Center 
Drive, Suite 3C25, Bethesda, MD 20892. Phone: 301-402-2313. Email: 
[email protected].

SUPPLEMENTARY INFORMATION: This notice is in accordance with the 21st 
Century Cures Act, NIH institutes are required to regularly update 
their strategic plans. The NIDCD's mission is to improve the lives of 
the millions of people with hearing loss and other communication 
disorders, spanning functions of hearing, balance, taste,

[[Page 5221]]

smell, voice, speech, and language. Our vision is that all those with 
disorders in these areas benefit from scientific discovery that informs 
effective and accessible treatments and improves quality of life. To 
get us there, NIDCD is seeking your best ideas to help as we develop 
our 2022-2026 Strategic Plan.

    Dated: January 22, 2020.
Timothy J. Wheeles,
Executive Officer, National Institute on Deafness and Other 
Communication Disorders, National Institutes of Health.
[FR Doc. 2020-01480 Filed 1-28-20; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.